Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89012119 | 8901211 | 9 | F | 2012 | 20160906 | 20121109 | 20160912 | EXP | CA-ROCHE-1153852 | ROCHE | 52.32 | YR | F | Y | 0.00000 | 20160912 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89012119 | 8901211 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0061D,S0062,S0068D,S0003C | 103976 | 375 | MG | SOLUTION FOR INJECTION | QOW | |||||
| 89012119 | 8901211 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0061D,S0062,S0068D,S0003C | 103976 | 375 | MG | SOLUTION FOR INJECTION | QOW | |||||
| 89012119 | 8901211 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0061D,S0062,S0068D,S0003C | 103976 | 375 | MG | SOLUTION FOR INJECTION | ||||||
| 89012119 | 8901211 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0061D,S0062,S0068D,S0003C | 103976 | SOLUTION FOR INJECTION | ||||||||
| 89012119 | 8901211 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0061D,S0062,S0068D,S0003C | 103976 | SOLUTION FOR INJECTION | ||||||||
| 89012119 | 8901211 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0061D,S0062,S0068D,S0003C | 103976 | SOLUTION FOR INJECTION | ||||||||
| 89012119 | 8901211 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0061D,S0062,S0068D,S0003C | 103976 | SOLUTION FOR INJECTION | ||||||||
| 89012119 | 8901211 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0061D,S0062,S0068D,S0003C | 103976 | SOLUTION FOR INJECTION | ||||||||
| 89012119 | 8901211 | 9 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 89012119 | 8901211 | 10 | C | PREDNISONE. | PREDNISONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 89012119 | 8901211 | 1 | Asthma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 89012119 | 8901211 | Arthritis | |
| 89012119 | 8901211 | Asthma | |
| 89012119 | 8901211 | Blister | |
| 89012119 | 8901211 | Blister rupture | |
| 89012119 | 8901211 | Chest discomfort | |
| 89012119 | 8901211 | Dyspnoea | |
| 89012119 | 8901211 | Fatigue | |
| 89012119 | 8901211 | Headache | |
| 89012119 | 8901211 | Hypertension | |
| 89012119 | 8901211 | Impaired driving ability | |
| 89012119 | 8901211 | Nasal congestion | |
| 89012119 | 8901211 | Oedema peripheral | |
| 89012119 | 8901211 | Photophobia | |
| 89012119 | 8901211 | Seasonal allergy | |
| 89012119 | 8901211 | Sense of oppression | |
| 89012119 | 8901211 | Temperature intolerance | |
| 89012119 | 8901211 | Thermal burn |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 89012119 | 8901211 | 1 | 20081208 | 0 | ||
| 89012119 | 8901211 | 2 | 20090330 | 0 | ||
| 89012119 | 8901211 | 3 | 20091207 | 0 | ||
| 89012119 | 8901211 | 4 | 20160307 | 0 | ||
| 89012119 | 8901211 | 5 | 20160404 | 0 | ||
| 89012119 | 8901211 | 6 | 20160725 | 0 | ||
| 89012119 | 8901211 | 7 | 20160805 | 0 | ||
| 89012119 | 8901211 | 8 | 20160822 | 0 |